loadpatents
name:-0.026638031005859
name:-0.025229930877686
name:-0.017405986785889
Auguet; Michel Patent Filings

Auguet; Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Auguet; Michel.The latest application filed is for "therapeutic use of botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy".

Company Profile
2.22.20
  • Auguet; Michel - Palaiseau FR
  • - Palaiseau FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Thiazole derivatives for treating dyskinesias caused by a chemical treatment
Grant 9,918,967 - Chabrier de Lassauniere , et al. March 20, 2
2018-03-20
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
Grant 9,259,458 - Favre , et al. February 16, 2
2016-02-16
Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
Grant 9,080,220 - Auguet , et al. July 14, 2
2015-07-14
Thiazole derivatives for treating dyskinesias caused by a chemical treatment
Grant 9,006,274 - Chabrier De Lassauniere , et al. April 14, 2
2015-04-14
Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus
Grant 08921322 -
2014-12-30
Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus
Grant 8,921,322 - Favre , et al. December 30, 2
2014-12-30
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
Grant 8,784,841 - Favre , et al. July 22, 2
2014-07-22
Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy
App 20140154781 - FAVRE; Christine ;   et al.
2014-06-05
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
Grant 8,273,359 - Favre , et al. September 25, 2
2012-09-25
Therapeutic Use Of At Least One Botulinum Neurotoxin In The Treatment Of Pain Associated With Diabetic Neuropathy
App 20110038893 - Favre; Christine ;   et al.
2011-02-17
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
App 20100068231 - Favre; Christine ;   et al.
2010-03-18
Use Of At Least One Botulinum Neurotoxin For Treating The Pain Induced By Therapeutic Treatments For The Aids Virus
App 20100029566 - Favre; Christine ;   et al.
2010-02-04
Use Of A Dihydroimidazopyrazoine Derivative For Treating Or Preventing Pain
App 20090270401 - Auguet; Michel ;   et al.
2009-10-29
Painkilling Association Comprising A Dihydroimidazopyrazine Derivative
App 20090270400 - Auguet; Michel ;   et al.
2009-10-29
Simultaneous, Separate Or Sequential Therapeutic Use Of At Least One Botulinum Neurotoxin And Of At Least One Opiate Derivative
App 20090232851 - Auguet; Michel ;   et al.
2009-09-17
Method for Quantifying a Cholinergic Neurotoxin in a Sample
App 20080247952 - Camara Y Ferrer; Jose-Antonio ;   et al.
2008-10-09
Thiazole Derivatives for Treating Dyskinesias Caused by a Chemical Treatment
App 20080207709 - Chabrier De Lassauniere; Pierre-Etienne ;   et al.
2008-08-28
Thiazole Derivatives for Treating Restless Legs Syndrome
App 20080194657 - Chabrier De Lassauniere; Pierre-Etienne ;   et al.
2008-08-14
Use of thiazole derivatives for preparing a medicine for protecting mitochondria
Grant 7,345,066 - Auguet , et al. March 18, 2
2008-03-18
Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
App 20080039451 - Auguet; Michel ;   et al.
2008-02-14
Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
Grant 7,285,664 - Harnett , et al. October 23, 2
2007-10-23
Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
App 20070185174 - Auguet; Michel ;   et al.
2007-08-09
New heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
App 20050227991 - Harnett, Jeremiah ;   et al.
2005-10-13
Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
Grant 6,936,715 - Harnett , et al. August 30, 2
2005-08-30
Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,887,891 - Harnett , et al. May 3, 2
2005-05-03
Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
Grant 6,872,738 - Auguet , et al. March 29, 2
2005-03-29
Use of thiazole derivatives for preparing a medicine for protecting mitochondria
App 20040248885 - Auguet, Michel ;   et al.
2004-12-09
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,809,088 - Chabrier de Lassauniere , et al. October 26, 2
2004-10-26
New derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
App 20040019084 - Harnett, Jeremiah ;   et al.
2004-01-29
Derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,630,461 - Chabrier de Lassauniere , et al. October 7, 2
2003-10-07
Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
Grant 6,605,637 - Harnett , et al. August 12, 2
2003-08-12
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,599,903 - Chabrier de Lassauniere , et al. July 29, 2
2003-07-29
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,586,454 - Chabrier de Lassauniere , et al. July 1, 2
2003-07-01
Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
App 20030105107 - Harnett, Jeremiah ;   et al.
2003-06-05
New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
App 20030078420 - Chabrier de Lassauniere, Pierre Etienne ;   et al.
2003-04-24
New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
App 20020045753 - Chabrier de Lassauniere, Pierre Etienne ;   et al.
2002-04-18
New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
App 20020042511 - Chabrier de Lassauniere, Pierre Etienne ;   et al.
2002-04-11
New derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
App 20020007062 - Chabrier de Lassauniere, Pierre Etienne ;   et al.
2002-01-17
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,335,445 - Chabrier de Lassauniere , et al. January 1, 2
2002-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed